ERBB2 and metastatic malignant neoplasm in the lymph nodes: Furthermore, HER2 overexpression was more frequent in patients with lymph node metastasis than in those free of lymph node metastasis (23.44% vs. 12.50%), but this association was not statistically significant (P = 0.21).